Does Traumatic Brain Injury Cause Risky Substance Use or Substance Use Disorder?

Does Traumatic Brain Injury Cause Risky Substance Use or Substance Use Disorder?
复制标题

DOI:
10.1016/j.biopsych.2021.07.013
复制
发表时间:
2022-03-01
影响因子:
10.6
通讯作者:
Corrigan JD
Corrigan JD
中科院分区:
医学1区
文献类型:
--
作者:
Olsen CM;Corrigan JD

文献摘要

参考文献

被引文献

相似文献

在患有创伤性脑损伤(TBI)的成年人中,危险物质使用的共同发生率很高,尽管尚不清楚TBI的神经系统后遗症是否会促进这种行为。我们建议,得出结论,TBI可能会导致危险物质的使用,它必须确定,TBI之前的危险物质的使用,必须排除与潜在的TBI和危险物质使用的可能性增加的混杂因素,必须有一个合理的作用机制。在这篇综述中,我们通过提供关键临床和临床前研究的概述来解决这些因素,并列出TBI可能增加危险物质使用的合理机制。人类和动物研究已经确定了TBI和危险物质使用之间的关联,尽管这种关联的强度各不相同。可能限制检测这种关系的因素包括由于物质、性别、受伤年龄和可能影响TBI和危险物质使用的可能性的混杂因素引起的差异性。我们提出了可能的机制,TBI可以增加物质的使用,包括损伤相关的神经可塑性,神经免疫信号的慢性变化,以及TBI相关的脑网络的改变。
There is a high co-occurrence of risky substance use among adults with traumatic brain injury (TBI), although it is unknown if the neurologic sequelae of TBI can promote this behavior. We propose that to conclude that TBI can cause risky substance use, it must be determined that TBI precedes risky substance use, that confounders with the potential to increase the likelihood of both TBI and risky substance use must be ruled out, and that there must be a plausible mechanism of action. In this review, we address these factors by providing an overview of key clinical and preclinical studies and list plausible mechanisms by which TBI could increase risky substance use. Human and animal studies have identified an association between TBI and risky substance use, although the strength of this association varies. Factors that may limit detection of this relationship include differential variability due to substance, sex, age of injury, and confounders that may influence the likelihood of both TBI and risky substance use. We propose possible mechanisms by which TBI could increase substance use that include damage-associated neuroplasticity, chronic changes in neuroimmune signaling, and TBI-associated alterations in brain networks.
DOI: 10.1016/j.bbi.2017.08.012
发表时间: 2018-01
期刊: Brain, behavior, and immunity
影响因子: --
作者:
Brown KT;Levis SC;O'Neill CE;Northcutt AL;Fabisiak TJ;Watkins LR;Bachtell RK
通讯作者: Bachtell RK
DOI: 10.1016/j.drugalcdep.2017.08.003
发表时间: 2017-11-01
影响因子: 4.2
作者:
Bachtell RK;Jones JD;Heinzerling KG;Beardsley PM;Comer SD
通讯作者: Comer SD
DOI: 10.4137/jen.s39887
发表时间: 2016
影响因子: --
作者:
Beckhauser TF;Francis-Oliveira J;De Pasquale R
通讯作者: De Pasquale R
DOI: 10.1089/neu.2019.6472
发表时间: 2019-08-21
影响因子: 4.2
作者:
Cannella, Lee Anne;Andrews, Allison M.;Ramirez, Servio H.
通讯作者: Ramirez, Servio H.
DOI: 10.1016/j.bbr.2019.112333
发表时间: 2020-02-03
影响因子: 2.7
作者:
Cannella, Lee Anne;Andrews, Allison M.;Ramirez, Servio H.
通讯作者: Ramirez, Servio H.